These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 32250176)
21. Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan. Akhmetova A; Kozhamkulov U; Bismilda V; Chingissova L; Abildaev T; Dymova M; Filipenko M; Ramanculov E Int J Tuberc Lung Dis; 2015 Feb; 19(2):179-84. PubMed ID: 25574916 [TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates. Huy NQ; Lucie C; Hoa TTT; Hung NV; Lan NTN; Son NT; Nhung NV; Anh DD; Anne-Laure B; Van Anh NT Emerg Microbes Infect; 2017 Oct; 6(10):e86. PubMed ID: 29018250 [TBL] [Abstract][Full Text] [Related]
23. Identification of a multidrug efflux pump in Mycobacterium smegmatis. Bansal A; Mallik D; Kar D; Ghosh AS FEMS Microbiol Lett; 2016 Jul; 363(13):. PubMed ID: 27190152 [TBL] [Abstract][Full Text] [Related]
24. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia. Bwalya P; Yamaguchi T; Mulundu G; Nakajima C; Mbulo G; Solo ES; Fukushima Y; Kasakwa K; Suzuki Y Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115 [TBL] [Abstract][Full Text] [Related]
25. Selection of in vitro mutants of pyrazinamide-resistant Mycobacterium tuberculosis. Bamaga M; Wright DJ; Zhang H Int J Antimicrob Agents; 2002 Oct; 20(4):275-81. PubMed ID: 12385684 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide. Aragón LM; Garrigó M; Moreno C; Español M; Coll P J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155 [TBL] [Abstract][Full Text] [Related]
27. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313 [TBL] [Abstract][Full Text] [Related]
28. Functional Characterization of Sirtuin-like Protein in Mycobacterium smegmatis. Gu L; Chen Y; Wang Q; Li X; Mi K; Deng H J Proteome Res; 2015 Nov; 14(11):4441-9. PubMed ID: 26375486 [TBL] [Abstract][Full Text] [Related]
29. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989 [TBL] [Abstract][Full Text] [Related]
30. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide. Sun Z; Zhang Y Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China. Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640 [TBL] [Abstract][Full Text] [Related]
32. Exploring the Pyrazinamide Drug Resistance Mechanism of Clinical Mutants T370P and W403G in Ribosomal Protein S1 of Mycobacterium tuberculosis. Rehman AU; Khan MT; Liu H; Wadood A; Malik SI; Chen HF J Chem Inf Model; 2019 Apr; 59(4):1584-1597. PubMed ID: 30810312 [TBL] [Abstract][Full Text] [Related]
33. Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. Zhang Y; Permar S; Sun Z J Med Microbiol; 2002 Jan; 51(1):42-49. PubMed ID: 11800471 [TBL] [Abstract][Full Text] [Related]
34. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia. Sengstake S; Bergval IL; Schuitema AR; de Beer JL; Phelan J; de Zwaan R; Clark TG; van Soolingen D; Anthony RM BMC Infect Dis; 2017 Jul; 17(1):491. PubMed ID: 28697808 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity. Raynaud C; Lanéelle MA; Senaratne RH; Draper P; Lanéelle G; Daffé M Microbiology (Reading); 1999 Jun; 145 ( Pt 6)():1359-1367. PubMed ID: 10411262 [TBL] [Abstract][Full Text] [Related]
37. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide]. Hong CY; Wang F; Gui J; Liu XL Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May; 46(5):436-9. PubMed ID: 22883731 [TBL] [Abstract][Full Text] [Related]
38. Drug resistance mechanism of PncA in Mycobacterium tuberculosis. Rajendran V; Sethumadhavan R J Biomol Struct Dyn; 2014; 32(2):209-21. PubMed ID: 23383724 [TBL] [Abstract][Full Text] [Related]
39. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea. Lee KW; Lee JM; Jung KS J Korean Med Sci; 2001 Oct; 16(5):537-43. PubMed ID: 11641519 [TBL] [Abstract][Full Text] [Related]
40. New mutations in pncA of in vitro selected pyrazinamide-resistant strains of Mycobacterium tuberculosis. Bamaga M; Zhang H; Wright DJ Microb Drug Resist; 2001; 7(3):223-8. PubMed ID: 11759083 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]